CDC-RFA-GH21-2164: Shoulder to Shoulder: Accompanying Ministries of Health in Central America in Strengthening Local and Global Health Security
Closed
This grant is closed. A newer notice from the same program is forecast: Capacity Building for National Immunization Programs in the Eastern Mediterranean Region (CDC-RFA-JG-27-0070). Status: Expected deadline February 12, 2027. It is in our archive of Centers for Disease Control - CGH notices from 2021.
Centers for Disease Control - CGH offered grants to any type of organization. It expected to make about 5 awards worth $210 million in total. Applications closed on July 16, 2021.
From the official notice on Grants.gov, last changed June 29, 2021. Checked November 7, 2026.
- Total funding$210 million
- Expected awards5
- Cost sharingNot required
- Funding typeCooperative Agreement
Key dates
| Posted | May 17, 2021 |
|---|---|
| Deadline | July 16, 2021 |
| Archived by Grants.gov | August 15, 2021 |
Who can apply
This opportunity was open to any type of organization.
- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
This an open competition NOFO
Is this a realistic fit?
- Most of the program's money (49% over five years) went to nonprofits.
- No cost sharing or match is required.
What the grant funds
The CDC Central American Region (CAR) for Division for Global Health Protection (DGHP) covers 8 countries (Belize, Costa Rica, El Salvador, Guatemala, Honduras, Nicaragua, Panama and the Dominican Republic). These countries are packed into a relatively small but biologically and socially diverse area of ~202,000 square miles. The geographic proximity of these countries contributes to frequent movement across borders and with the United States by people, animals and often pathogens, due to travel, trade and migration. Regional capacity to detect and diagnose emerging infections is variable among different countries in Central America and often inadequate especially outside of capital cities. Among the main public health problems facing CAR are limitations to quickly and efficiently review and analyze data and information; challenges with consistent quality in the national reference laboratories; insufficient regulations and standardization of technical and biosafety procedures for quality control and quality assurance; and a lack of integration of epidemiological surveillance, laboratory and hospital systems. Efforts supported through this NOFO should align with both CDC and national goals for CAR. The recipients will work with regional countries to accomplish four key outcomes: (1) Increased and improved public health surveillance systems, (2) Strengthening of non-outbreak-related public health activities impacted by outbreaks (3) Enhanced public health laboratory capacity, and (4) Enhanced outbreak/epidemic response. Additionally, this NOFO aims to increase collaboration among CAR countries for improved regional surveillance and laboratory systems, to enhance existing integrated national public health networks (epidemiology, laboratory, clinical) and finally to develop international-caliber national public health surveillance and response systems that will be regional resources. Activities to support these priorities will require assessment of capabilities, capacities, infrastructure, and training needs, with implementation through mentoring and technical assistance for the purpose of developing national guidelines and providing training in international standards. The long-term direction of this NOFO is to support CAR in buildings capacity and strengthening public health systems in order to secure sustainable public health infrastructure and systems.
Who has won Protecting and Improving Health Globally: Building and Strengthening Public Health Impact, Systems, Capacity and Security grants before
From fiscal 2021 to 2025, Protecting and Improving Health Globally: Building and Strengthening Public Health Impact, Systems, Capacity and Security (93.318) awarded $1.3 billion across 306 grant awards, an average of $4.3 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| African Field Epidemiology Network LTD | 6 | $147 million | |
| The Task Force for Global Health, Inc. | Georgia | 7 | $138 million |
| World Health Organization, Somalia | 14 | $125 million | |
| Association of Public Health Laboratories, Inc. (the) | Maryland | 3 | $61.5 million |
| The Johns Hopkins University | Maryland | 5 | $42.7 million |
Applying now
This notice no longer takes applications. Apply under the newer notice, CDC-RFA-JG-27-0070, which is forecast.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is CDC-RFA-GH21-2164 still open?
No. It closed on July 16, 2021. A newer notice is forecast: CDC-RFA-JG-27-0070, expected deadline February 12, 2027.
Who can apply for Shoulder to Shoulder: Accompanying Ministries of Health in Central America in Strengthening Local and Global Health Security?
Centers for Disease Control - CGH accepted applications from any type of organization. The notice adds further conditions, so read its eligibility section.
What is the deadline for Shoulder to Shoulder: Accompanying Ministries of Health in Central America in Strengthening Local and Global Health Security?
Closed July 16, 2021. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
About $210 million in total across about 5 awards.
Who has won Protecting and Improving Health Globally: Building and Strengthening Public Health Impact, Systems, Capacity and Security grants before?
The largest recipients over five fiscal years were African Field Epidemiology Network LTD, The Task Force for Global Health, Inc., World Health Organization, Somalia. The program made 306 awards worth $1.3 billion in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)